Symbol: |
KCTD1
|
Description: |
potassium channel tetramerisation domain containing 1 [Source:HGNC Symbol;Acc:18249]
|
Location: |
Chr18:24034874-24237365[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:423
Gene |
Compound |
Gen_sig |
Exp_pattern |
KCTD1 |
2-[(Dimethylamino)-1-ethyl]-5,6-dihydro-2,3-dimethoxy-8,9-me thylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Formic Acid |
0.024 |
Up |
KCTD1 |
NSC 725127 |
0.03 |
Up |
KCTD1 |
2,2'-(1,4-phenylene)bis(1,3-dimethylimidazolidine) |
0.001 |
Up |
KCTD1 |
dechlorinated rebeccamycin |
0.015 |
Up |
KCTD1 |
Bis-{(5,6-dihydro-5,11-diketo-11H-indeno[1,2-c]isoquinoline) -6-propylamino}ethane Bis(trifluoroacetate |
0.047 |
Up |
KCTD1 |
1-(3-diethylarsino-3-thio-2-methyl-1-oxopropyl)-L-proline |
0.005 |
Up |
KCTD1 |
1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one |
0.02 |
Up |
KCTD1 |
NSC 732719 |
0.013 |
Up |
KCTD1 |
NSC 733155 |
0.034 |
Up |
KCTD1 |
Everolimus |
0.004 |
Down |
KCTD1 |
4-(4-Chloro-phenyl)-7a-methyl-2,5-diphenyl-7aH-cyclopenta[b] pyran-7-one |
0.026 |
Up |
KCTD1 |
4-[(Z)-2-(5-nitro-2-furyl)ethenyl]-6-(4-phenylpiperazin-1-yl )-1,3,5-triazin-2-ylamine |
0.011 |
Up |
KCTD1 |
4-[(Z)-2-phenylethenyl]-6-(3,5,5-trimethyl-4,5-dihydro-1H-py razol-1-yl)-1,3,5-triazin-2-ylamine |
0.006 |
Up |
KCTD1 |
NSC 736154 |
0.001 |
Up |
KCTD1 |
6-(3-Aminopropyl)-5,6-dihyro-9-iodo-3-nitro-5,11-dioxo-11H-i ndeno[1,2-c]isoquinoline Hydrochloride |
0.007 |
Up |
Expression pattern: Sensitivity / Resistance
Total:29 Current:26
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:13
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:23
Total:2 Current:1
[First] [Prev]  Next Last 
|